Ticker LaunchLondon · AIM · IPO · TRLS
Trellus Health Plc
Trellus Health Plc (TRLS) was admitted to AIM on May 28, 2021, raising £28.5M at 40p per share. Its market capitalization at admission was about £64.6M. N+1 Singer acted as nominated adviser, with N+1 Singer (Sole Bookrunner, Nominated Adviser and Corporate Broker) as broker.
Trellus Health commercialises a resilience-based connected health solution for chronic condition management, including inflammatory bowel disease, under an exclusive licence from the Icahn School of Medicine at Mount Sinai.
- Type
- IPO
- Market
- AIM
- Ticker (TIDM)
- TRLS
- Admitted
- May 28, 2021
- Offer price
- 40p
- Raised
- £28.5M
- Market cap at admission
- £64.6M
- Nominated adviser
- N+1 Singer
- Brokers
- N+1 Singer (Sole Bookrunner, Nominated Adviser and Corporate Broker)
- Sector
- Biotech & pharma
- Country
- United Kingdom / United States (New York)
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Shares in issue at admission
- ISIN
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Arecor Therapeutics PlcAIM · Jun 3, 2021
- Aquila Energy Efficiency Trust PlcMain Market · Jun 2, 2021
- Belluscura PlcAIM · May 28, 2021
- Taylor Maritime Investments LimitedMain Market · May 27, 2021
- Dianomi PlcAIM · May 24, 2021
- Kitwave Group PlcAIM · May 24, 2021